NDC 0078-0986-45
MAYZENT 2 mg/1
siponimod · TABLET, FILM COATED
Mayzent (siponimod) is an oral tablet used to treat secondary progressive multiple sclerosis, a progressive form of MS where symptoms gradually worsen over time. It works by modulating sphingosine 1-phosphate receptors to help reduce disease activity and slow progression.
Key Facts
- Brand Name
- MAYZENT
- Generic Name
- siponimod
- NDC Code (Package)
0078-0986-45- NDC Code (Product)
0078-0986- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 2 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA209884
- Drug Class
- Sphingosine 1-phosphate Receptor Modulator [EPC]
- Marketing Start
- 03/26/2019
Recall History
No Recall HistoryView Full Drug Page
MAYZENT — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.